Impact of revised antral follicle count threshold on PCOS diagnosis: A comparative clinical study
- 1Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, Delhi, India
- 2Division of Reproductive Biology, Maternal and Child Health, Indian Council of Medical Research, New Delhi, Delhi, India
- 3Department of Computer Science, Ashoka University, Sonipat, Haryana, India
Abstract
Objective: To evaluate the clinical impact of the revised antral follicle count (AFC) threshold on polycystic ovary syndrome (PCOS) diagnosis. Methods: A retrospective cross-sectional observational study including women diagnosed using the Rotterdam criteria, stratified by AFC: 12–19 (low AFC) and ≥20 (high AFC). Clinical, metabolic, and hormonal parameters were compared against controls and amongst low and high AFC group. Results: Of 336 PCOS women, 208 (62%) had an AFC between 12 and 19 and would not meet the revised ≥20 follicle threshold for the diagnosis of polycystic morphology. These women had worse metabolic and androgenic profiles than controls, and were similar to the high AFC group. Conclusion: Excluding low AFC women may misclassify patients who require clinical care.
Related
- Validation of a Revised V-Slope Algorithm for Automated First Ventilatory Threshold Detection in Healthy Adults
- Neuropsychiatric symptoms across the revised Alzheimer's disease clinical staging framework: A review of current evidence and implications
- Interfacility Variation in Diagnosis and Tocolysis for Threatened Preterm Labor and Its Association With Gestational Age Threshold for Neonatal Intensive Care Unit Admission: A Cross-Sectional Survey of Perinatal Centers in the Chugoku-Shikoku Region of Western Japan.
- Clinical Implications of the Age Threshold in the 2022 ACR/EULAR Classification Criteria for Takayasu Arteritis: A Real-World Study of Patients Aged over 61 Years
- Pediatric Headache: A Practical Approach to Clinical Diagnosis and Management
BibTeX
@article{kamboj2026impact,
title = {{Impact of revised antral follicle count threshold on PCOS diagnosis: A comparative clinical study}},
author = {Saloni Kamboj and Neena Malhotra and Reeta Mahey and Taruna Arora and Aditi Goyal and Snigdha Soni and Anshu Jyoti and Spondita Banerjee and Rintu Kutum},
journal = {PLOS One},
year = {2026},
month = oct,
doi = {10.1371/journal.pone.0358554},
url = {https://doi.org/10.1371/journal.pone.0358554},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Impact of revised antral follicle count threshold on PCOS diagnosis: A comparative clinical study
AU - Saloni Kamboj
AU - Neena Malhotra
AU - Reeta Mahey
AU - Taruna Arora
AU - Aditi Goyal
AU - Snigdha Soni
AU - Anshu Jyoti
AU - Spondita Banerjee
AU - Rintu Kutum
PY - 2026
DA - 2026/10/15
JO - PLOS One
DO - 10.1371/journal.pone.0358554
UR - https://doi.org/10.1371/journal.pone.0358554
AB - Objective: To evaluate the clinical impact of the revised antral follicle count (AFC) threshold on polycystic ovary syndrome (PCOS) diagnosis. Methods: A retrospective cross-sectional observational study including women diagnosed using the Rotterdam criteria, stratified by AFC: 12–19 (low AFC) and ≥20 (high AFC). Clinical, metabolic, and hormonal parameters were compared against controls and amongst low and high AFC group. Results: Of 336 PCOS women, 208 (62%) had an AFC between 12 and 19 and would not meet the revised ≥20 follicle threshold for the diagnosis of polycystic morphology. These women had worse metabolic and androgenic profiles than controls, and were similar to the high AFC group. Conclusion: Excluding low AFC women may misclassify patients who require clinical care.
SN - 1932-6203
ER -